GENAERA RECEIVES PATENT FOR GENE VARIANTS OF INTERLEUKIN-9 RECEPTOR

A A

Genaera Corporation today announced issuance by the United States Patent and Trademark Office of patent number 7,056,698 entitled "Nucleic Acids Encoding Interleukin-9 Receptor Variants."

Drug Newswire (http://www.euro2day.gr/articlesfna/16501875/)